A European Institute for Biomedical Imaging Research (EIBIR)/European Network for Cell Imaging and Tracking Expertise (ENCITE) educational workshop, called “Cells at work: Imaging in health and disease,” will take place May 18-19 at the University of Mons in Belgium.
A European Institute for Biomedical Imaging Research (EIBIR)/European Network for Cell Imaging and Tracking Expertise (ENCITE) educational workshop, called “Cells at work: Imaging in health and disease,” will take place May 18-19 at the University of Mons in Belgium.
ENCITE is a collaborative project coordinated by EIBIR. It is related to the theme “Cooperation health: in vivo image-guidance for cell therapy,” and is supported by the European Commission within the 7th Framework Programme for Research. It started in June 2009, thanks to a financial contribution of €12 million. ENCITE is a four-year project and has 29 project partners from 11 countries with expertise in the field of cell imaging.
The mission of the project is to develop and test new MR and optical imaging methods and biomarkers to get a more comprehensive picture of cell fate and reactions of the immune system, and ultimately to improve and further develop cell therapy for the benefit of the European patient. Details on the interim results can be found here.
The deadline to register is April 20.
For more information, please contact: office@eibir.org.
ACR Collaborative Model Achieves 20 Percent Improvement in PI-QUAL Scores for Prostate MRI
May 9th 2024Using a learning network model to discuss challenges and share insights among radiology departments from five different organizations, researchers noted that 87 percent of audited prostate MRI exams had PI-QUAL scores > 4 at the conclusion of the collaborative program.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.